Ordinary Share Capital Cambiamento Data
AstraZeneca USD 387M 0 2023-09
Canopy Growth CAD 8.22B 154.56M 2023-09
Gilead Sciences USD 1000K 0 2023-09
Pacira USD 46K 0 2023-12
Perrigo USD 6.86B 26.7M 2023-09
Prestige Brands USD 553K 1000 2023-12
Roche Holding CHF 107M 0 2023-06
Supernus Pharmaceuticals USD 55K 0 2023-12



Novartis Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.